Übersicht · Eingereicht: —
CC_585030/2023
A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER
Verletzungs-Hauptverfahren:UPC_CFI_15/2023
NichtigkeitWiderklage auf NichtigkeitParis CDCounterclaim for revocation—
Parteien
Kläger
- Meril Italy S.r.l.(Meril Group)
- Meril GmbH(Meril Group)
- Meril Life Sciences Pvt Ltd.(Meril Group)
Vertreter: Emmanuel Larere (Gide Loyrette Nouel AARPI); Raphaëlle Dequiré-Portier (Gide Loyrette Nouel AARPI); Jean-Robert Callon de Lamarck (Regimbeau); Anne Seibel (Regimbeau); Andreas von Falck (Hogan Lovells International LLP)
Beklagte
- Edwards Lifesciences Corporation(Edwards Lifesciences Group)
Vertreter: Boris Kreye (Bird & Bird LLP); Elsa Tzschoppe (Bird & Bird LLP); Bernhard Thum (Thum & Partner); Jonas Weickert (Thum & Partner); Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Tessa Waldron (Powell Gilbert (Europe) LLP); Bryce Matthewson (Powell Gilbert (Europe) LLP)
Richter
Französische Kammer — Einzelrichter anonymisiert.
- Panel member (anonymized)Presiding judge and judge-rapporteur
- Panel member (anonymized)Legally qualified judge
- Panel member (anonymized)Technically qualified judge
Patente
- EP 3 646 825
CPC-Codes: A61F2220/0075, A61F2/2436, A61F2250/0065, A61F2/2418, A61F2230/0054, A61F2250/0069, A61F2/2433
Technologiebereich: Medical Devices · Implants
Sektor: Pharmaceutical & Medical
Ausgang
Patent geändertAufrechterhalten in geänderter Fassung
Eingereicht: —
Erste Entscheidung: 19. Juli 2024
Sprache: —
Decision of the Paris Central Division rejecting the revocation action by Meril Italy Srl and the counterclaims for revocation by Meril GmbH and Meril Life Sciences Pvt Ltd against Edwards Lifesciences Corporation's EP 3 646 825 (prosthetic heart valve). The patent is maintained as amended in auxiliary request II, which limits claims to a frame made up entirely of hexagonal cells. The revocation claimants (60%) and defendant (40%) share costs.
Ansprüche
Streitigall
Geändertall
Hinweise: Counterclaim for revocation by Meril GmbH/Meril Life Sciences against EP3646825; same decision as ACT_551308/2023 — patent maintained in amended form per auxiliary request II; specific amended claim 1 text reproduced in excerpt.